IRIS
DE SARRO, Angelina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.139
EU - Europa 4.110
AS - Asia 2.318
SA - Sud America 756
AF - Africa 75
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 11.406
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.065
RU - Federazione Russa 1.980
SG - Singapore 993
BR - Brasile 659
CN - Cina 659
SE - Svezia 524
IE - Irlanda 511
UA - Ucraina 343
HK - Hong Kong 239
DE - Germania 234
VN - Vietnam 187
GB - Regno Unito 149
FI - Finlandia 121
FR - Francia 104
IN - India 66
IT - Italia 41
CA - Canada 33
AR - Argentina 32
BD - Bangladesh 25
MX - Messico 24
ZA - Sudafrica 23
JP - Giappone 21
TR - Turchia 20
AT - Austria 19
EC - Ecuador 19
BE - Belgio 17
PK - Pakistan 16
MA - Marocco 15
PL - Polonia 14
JO - Giordania 12
UZ - Uzbekistan 12
CL - Cile 10
ES - Italia 10
IQ - Iraq 10
NL - Olanda 10
AE - Emirati Arabi Uniti 9
CO - Colombia 9
CZ - Repubblica Ceca 8
EG - Egitto 8
VE - Venezuela 8
PE - Perù 7
RS - Serbia 6
UY - Uruguay 6
ID - Indonesia 5
MN - Mongolia 5
PY - Paraguay 5
TN - Tunisia 5
AZ - Azerbaigian 4
CI - Costa d'Avorio 4
DZ - Algeria 4
IL - Israele 4
IR - Iran 4
KE - Kenya 4
PA - Panama 4
SA - Arabia Saudita 4
SN - Senegal 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KR - Corea 3
NG - Nigeria 3
NP - Nepal 3
OM - Oman 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
BW - Botswana 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
LB - Libano 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
ET - Etiopia 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
PR - Porto Rico 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
Totale 11.406
Salva come PNG Salva come JPEG
Città #
Jacksonville 671
Moscow 651
Singapore 553
Dublin 511
Ashburn 498
Dallas 490
Chandler 425
Beijing 265
Nyköping 263
Hong Kong 237
San Jose 174
Dong Ket 125
Princeton 105
Cambridge 104
Lauterbourg 92
The Dalles 92
Boardman 84
Los Angeles 84
Des Moines 78
Medford 76
Ann Arbor 65
Dearborn 51
Buffalo 50
São Paulo 40
Woodbridge 37
Pune 29
Tianjin 27
New York 25
Wilmington 25
Guangzhou 24
Belo Horizonte 22
Ho Chi Minh City 22
Jinan 21
Orem 20
Rio de Janeiro 20
Lancaster 19
Redondo Beach 19
Shenyang 18
Vienna 18
Brussels 17
Houston 16
Seattle 15
Council Bluffs 14
Frankfurt am Main 14
Hyderabad 14
London 14
Montreal 13
Auburn Hills 12
Brooklyn 12
Santa Clara 12
Shenzhen 12
Tokyo 12
Warsaw 12
Curitiba 11
Hangzhou 11
Hanoi 11
Hebei 11
Helsinki 11
Johannesburg 11
Munich 11
Amman 10
Amsterdam 10
Ningbo 10
Poplar 10
Porto Alegre 10
Saint Petersburg 10
San Mateo 10
Stockholm 10
Tashkent 10
Washington 10
Campinas 9
Monmouth Junction 9
Taizhou 9
Zhengzhou 9
Chicago 8
Denver 8
Milan 8
Morikitamachi 8
Norwalk 8
Phoenix 8
Quito 8
Salvador 8
San Francisco 8
Shanghai 8
Ankara 7
Brasília 7
Casablanca 7
Contagem 7
Manchester 7
Nuremberg 7
Toronto 7
Turku 7
Atlanta 6
Augusta 6
Belgrade 6
Cape Town 6
Changsha 6
Chennai 6
Edinburgh 6
Juiz de Fora 6
Totale 6.716
Salva come PNG Salva come JPEG
Nome #
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 298
1,4-benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice 256
5-lipoxygenase knockout mice exhibit a resistance to acute pancreatitis induced by cerulein 245
5-AMINOISOQUINOLINONE REDUCES COLON INJURY BY EXPERIMENTAL COLITIS 229
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 210
Absence of endogenous interleukin-6 enhances the inflammatory response during acute pancreatitis induced by cerulein in mice 205
7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists 199
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 192
Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice 189
Amoxicillin and amoxicillin plus clavulanate: a safety review 189
Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolates 175
Azirino[1,2-d][1,4]benzodiazepine derivatives and related 1,4- benzodiazepines as anticonvulsant agents in DBA/2 mice 170
Activity of nine fluoroquinolones against strains of Bordetella bronchiseptica 166
Focus: Linguistic, cognitive, and computational perspectives 160
7-nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 158
Anticonvulsant activity and plasma level of 2,3-benzodiazepin- 4-ones (CFMs) in genetically epilepsy-prone rats 156
Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method 155
Amoxicillin and amoxicillin plus clavulanate: a safety review. 154
Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin 150
New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance 146
Adverse reactions to fluoroquinolones. An overview on mechanistic aspects 144
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 142
Beneficial effects of GPI 6150, an inhibitor of poly(ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion 140
Amelioration of joint disease in a rat model of collagen- induced arthritis by M40403, a superoxide dismutase mimetic 134
Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury 131
BENEFICIAL EFFECTS OF 5-AMINOISOQUINOLINONE, A NOVEL, POTENT, WATER-SOLUBLE, INHIBITOR OF POLY(ADP-RIBOSE)POLYMERASE, IN A RAT MODEL OF SPLANCHNIC ARTERY OCCLUSION AND REPERFUSION 131
Beneficial effects of n-acetylcysteine on ischaemic brain injury 130
Geometric models in classical thermomechanics of continua with applications to irreversible phenomena 127
Synthesis and pharmacological evaluation of 4-aryl-6,7- dimethoxyphthalazines as anticonvulsant agents 118
Novel potent AMPA/kainate receptor antagonists: Synthesis and anticonvulsant activity of a series of 2-[(4- alkylsemicarbazono)-(4-aminophenyl)methyl]-4,5- methylenedioxyphenylacetic acid alkyl esters 117
Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury 114
Protective effects of melatonin in ischemic brain injury 111
Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury 111
Synthesis and anticonvulsant activity of novel and potent 6,7- methylenedioxyphthalazin-1(2H)-ones 110
NOVEL ANNELATED 1,4-BENZODIAZEPINES AND 1,5-BENZODIAZEPINES 109
Regulation of prostaglandin generation in carrageenan-induced pleurisy by inducible nitric oxide synthase in knockout mice 109
Susceptibility to audiogenic seizure and neurotransmitter amino acid levels in different brain areas of IL-6-deficient mice 107
Synthesis and anticonvulsant activity of novel and potent 1- aryl-7,8-methylenedioxy-1,2,3,5-tetrahydro-4H-2,3- benzodiazepin-4-ones 107
Effects of melatonin on ischemic brain injury 106
Synthesis and anticonvulsant activity of triazolo[4,5-c][2,3]benzodiazepines 105
Synthesis and pharmacological properties of new 3- ethoxycarbonyl-11H-[1,2,4]triazolo[4,5-c][2,3]benzodiazepines 102
Synthesis and anticonvulsant activity of novel and potent 2,3- benzodiazepine AMPA/kainate receptor antagonists 97
Role of 5-lipoxygenase in the multiple organ failure induced by zymosan 97
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents 97
Synthesis and anticonvulsant activity of new 11H-triazolo[4,5- c] [2,3]benzodiazepines 96
Role of tight junction derangement in the endothelial dysfunction elicited by exogenous and endogenous peroxynitrite and poly(ADP-ribose) synthetase 96
New and investigational antimicrobials for the treatment of severe skin infections 96
Protective effects of n-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat 96
Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice 95
GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice 95
The tyrosine kinase inhibitor tyrphostin AG126 reduces the development of acute and chronic inflammation 94
Influence of retigabine on the anticonvulsant activity of some antiepileptic drugs against audiogenic seizures in DBA/2 mice 94
New and investigational triazole agents for the treatment of invasive fungal infections 94
Beneficial effects of GW274150 treatment on the development of experimental colitis induced by dinitrobenzene sulfonic acid. 93
Synthesis and evaluation of pharmacological properties of novel annelated 2,3-benzodiazepine derivatives 93
Effect of N-acetylcysteine on gentamicin-mediated nephropathy in rats 93
Influence of some beta-adrenoceptor antagonists on the anticonvulsant potency of antiepileptic drugs against audiogenic seizures in DBA/2 mice 93
RELATIONSHIP BETWEEN STRUCTURE AND CONVULSANT PROPERTIES OF SOME BETA-LACTAM ANTIBIOTICS FOLLOWING INTRACEREBROVENTRICULAR MICROINJECTION IN RATS 93
Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion 92
Linear hyperbolic systems of order-k in bounded and unbounded sets. Stability of complete controllability 92
Influence of D-cycloserine on the anticonvulsant activity of some antiepileptic drugs against audiogenic seizures in DBA/2 mice 92
Benzodiazepine receptor affinities, behavioral, and anticonvulsant activity of 2-aryl-2,5-dihydropyridazino[4,3- b]indol-3(3H)-ones in mice 91
Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion 89
Structure-activity relationships in thienodiazepine and benzodiazepine derivatives. 88
Convulsant effects of some xanthine: Derivatives in genetically epilepsy-prone rats 88
Inducible nitric oxide synthase - Knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan 87
Green tea polyphenol extract attenuates colon injury induced by experimental colitis 86
ERYTHROPOIETIN REDUCES THE DEVELOPMENT OF EXPERIMENTAL INFLAMMATORY BOWEL DISEASE 86
Quinolones potentiate cefazolin-induced seizures in DBA/2 mice. 86
Tolerance and pharmacokinetics of ciprofloxacin in the chick. Preliminary experience in subjects of pediatric age with urinary tract infections (UTI) 86
Protective effects of Celecoxib on lung injury and red blood cells modification induced by carrageenan in the rat 86
NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice 85
Synthesis and anticonvulsant properties of 2,3,3a,4-tetrahydro- 1H-pyrrolo[1,2-a]benzimidazol-1-one derivatives 84
Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats 83
Topiramate potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 83
Role of interleukin-6 in a non septic shock model induced by zymosan 83
Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats 82
SYNTHESIS AND ANTICONVULSANT PROPERTIES OF 3-(1,3,4-THIADIAZOL- 2-YL)THIAZOLIDIN-4-ONES 82
Role of IL-6 in the pleurisy and lung injury caused by carrageenan 82
Effects of some excitatory amino acid antagonists and drugs enhancing gamma-aminobutyric acid neurotransmission on pefloxacin-induced seizures in DBA/2 mice 81
Effect of melatonin on cellular energy depletion mediated by peroxynitrite and poly (ADP-ribose) synthetase activation in an acute model of inflammation 81
Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents 80
Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice 80
The charta of milan: basic criteria for the appropriate and accurate use of antibiotics: recommendations of the italian society of chemotherapy. 80
Inducibile nitric oxide synthase knock out mice exhibit resistance to pleurisy lung injury caused by carrageenan 79
WWW.ecm.farmacovigilanza.org: An Italian website for CME in pharmacovigilance 78
Role of interleukin-6 in splanchnic artery occlusion shock. 78
Role of interleukin-6 in a non-septic shock model induced by zymosan 78
Enhanced susceptibility of pentylenetetrazole kindled mice to quinolone effects 77
Synthesis and anticonvulsant activity of new 2,3- benzodiazepines as AMPA receptor antagonists 77
Molecular requirement for anticonvulsant activity in a series of thiazolo-1,4-benzodiazepine derivatives and comparison with classical benzodiazepines. 74
Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice 72
Reversible orofacial dyskinesia after ofloxacin treatment 72
Relationship between anticonvulsant activity and plasma level of some 2,3-benzodiazepines in genetically epilepsy-prone rats 71
Synthesis and anticonvulsant activity of novel non competitive as AMPA receptor antagonists. 70
INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE MODULATE SIGNAL TRANSDUCTION PATHWAYS AND SECONDARY DAMAGE IN EXPERIMENTAL SPINAL CORD TRAUMA. 70
Interleukin-6 knock out mice exhibit a resistance to splanchnic artery occlusion shock 69
Role of free radicals and poly(ADP-ribose) synthetase in intestinal tight junction permeability 69
THALIDOMIDE TREATMENT REDUCES COLON INJURY INDUCED BY EXPERIMENTAL COLITIS 68
Effects of novel-6-desfluoroquinolones and classic quinolones on Pentylenetenazole induced seijures in mice 63
Totale 11.299
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.932
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021151 0 0 0 0 0 0 0 0 0 0 0 151
2021/2022630 11 79 16 11 24 0 40 28 6 66 156 193
2022/20231.704 146 106 52 139 161 191 21 131 659 11 70 17
2023/2024466 52 70 27 108 25 84 12 47 1 16 4 20
2024/20251.750 20 18 58 113 101 35 9 477 449 59 111 300
2025/20264.633 161 303 455 310 423 1.189 532 504 485 157 69 45
Totale 11.486